Always seek the court’s permission before requesting the limitation of the patent outside the judicial proceeding: the tiotropium case
On 9 February 2023 the Supreme Court upheld a Judgment issued by the Barcelona Provincial ...
On 9 February 2023 the Supreme Court upheld a Judgment issued by the Barcelona Provincial ...
On 20 January 2023, the 15th Section of the Barcelona Provincial Court overturned interim injunctions ...
In its recent judgment of 4 November 2022, the Court of Appeal of Barcelona ruled ...
Last Friday 17 February 2023 was a sad day for the EU. Germany decided to ...
[et_pb_section fb_built=”1″ _builder_version=”3.19.5″][et_pb_row _builder_version=”3.0.48″ background_size=”initial” background_position=”top_left” background_repeat=”repeat”][et_pb_column type=”2_5″ _builder_version=”3.0.47″ parallax=”off” parallax_method=”on”][et_pb_image src=”https://vidalquadrasramon.com/wp-content/uploads/2022/10/drugs-2.jpg” _builder_version=”3.19.5″][/et_pb_image][/et_pb_column][et_pb_column type=”3_5″ _builder_version=”3.0.47″ ...
On 2 July 2022, the SPC manufacturing waiver, approved by EU Regulation 2019/933, came into ...
[et_pb_section fb_built=”1″ _builder_version=”3.19.5″][et_pb_row _builder_version=”3.0.48″ background_size=”initial” background_position=”top_left” background_repeat=”repeat”][et_pb_column type=”2_5″ _builder_version=”3.0.47″ parallax=”off” parallax_method=”on”][et_pb_image src=”https://vidalquadrasramon.com/wp-content/uploads/2022/07/VQR_LAW_21.07.22-1.jpg” _builder_version=”3.19.5″][/et_pb_image][/et_pb_column][et_pb_column type=”3_5″ _builder_version=”3.0.47″ ...
In this commentary we will refer to the Judgment of the Barcelona Provincial Court (15th Section) 1610/2021 of 27 July (ECLI:ES:APB:2021:8276). We do not intend to provide a critical commentary on the Judgment, but simply to refer to some aspects that we have considered to be of interest in patent matters and, in particular, to the legal analysis of the plausibility of a technical effect on which the inventive step of patent EP 1 203 761 (EP'761) was based. This was the CCP's basic patent on the product cinacalcet.
In the Order of 19 July 2021 (ECLI:ES:JMB:2021:2692A) Commercial Court No. 1 of Barcelona dismissed a preliminary injunction request by BAYER against four companies that launched generic medicines containing the active ingredient sorafenib in the form of its tosylate salt on the Spanish market.
An in depth study on the ongoing Standard Essential Patents (SEP) reform in the frame of the European Commission’s innovation promotion policy supported by a Pilot Study.







